CARB-X, the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator, is a global nonprofit partnership focused on supporting the development of new antibacterial products. Its mission is to strengthen the pipeline of vaccines, rapid diagnostics, antibiotics and non-traditional products that prevent, diagnose and treat life-threatening bacterial infections. It was launched in the summer of 2016 at the Boston University School of Law, where its Executive Director, Kevin Outterson, is a professor of law who teaches health law and corporate law and co-directs the Health Law Program.
Facts
Founding Year In the Other Atlases
Found In
Also in Geography Atlas: where this subject is found.
Source Research Organization Registry (ROR): Research Organization Registry record for CARB-Xlocations, geonames_details nameQuote, locations, geonames_details name
"name": "Boston"
Sources
1. CARB-X (Wikipedia)
Lead sectionQuote, Lead section
was launched in summer of 2016
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.